Dexfenfluramine and neurotoxicity
Blundell, J.E.
Lancet 339(8789): 359-60; Author Reply 360-1
1992
ISSN/ISBN: 0140-6736 PMID: 1346426 Document Number: 388472
Document emailed within 1 workday
Related Documents
Rothman, R.B. 1997: Brain serotonin neurotoxicity and fenfluramine and dexfenfluramine JAMA 278(24): 2142Enzi, G. 1997: A multicenter open study of dexfenfluramine in Italy. the efficacy and safety of using dexfenfluramine in treating patients with simple or complicated obesity. the DIMOS Group Terapevticheskii Arkhiv 69(5): 71-75
Roongpisuthipong, C.; Panpakdee, O.; Boontawee, A.; Kulapongse, S.; Tanphaichitr, V. 1999: Possible thermogenesis with dexfenfluramine Journal of the Medical Association of Thailand 82(2): 150-159
1996: Dexfenfluramine for obesity Medical Letter on Drugs and Therapeutics 38(979): 64-65
Astrup, A.; Andersen, T.; Quaade, F. 1987: Dexfenfluramine--a new anorexic agent Ugeskrift for Laeger 149(40): 2726-2727
Blundell, J.E.; Hill, A.J. 1992: Dexfenfluramine and appetite in humans International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 16(Suppl 3): S51-S59
Toornvliet, A.C.; Pijl, H.; Meinders, A.E. 1994: Major depression during dexfenfluramine treatment International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 18(9): 650
Schutz, Y.; Munger, R.; Dériaz, O.; Jéquier, E. 1992: Effect of dexfenfluramine on energy expenditure in man International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 16(Suppl 3): S61-S66
Mathus-Vliegen, E.M. 1993: Prolonged surveillance of dexfenfluramine in severe obesity Netherlands Journal of Medicine 43(5-6): 246-253
Bergmann, J.F. 2001: Facts, fakes and "biblio". do internists still have something to learn about dexfenfluramine? Annales de Medecine Interne 152(7): 427-428
Jensen, K. 1998: Recall of slimming agents fenfluramine and dexfenfluramine--for what reason? Ugeskrift for Laeger 160(36): 5217
Bories, J.M.; Bauret, P.; Larrey, D.; Michel, H. 1992: Acute pancreatitis and dexfenfluramine (Isomeride): apropos of a case Gastroenterologie Clinique et Biologique 16(10): 817-818
Fantino, M. 1989: Dexfenfluramine and feeding behavior. Clinical and pharmacoclinical studies Annales de Medecine Interne 140(Suppl 1): 12-16
Rothwell, N.J.; Le Feuvre, R.A. 1992: Thermogenesis, brown adipose tissue and dexfenfluramine in animal studies International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 16(Suppl 3): S67-S71
Ema, M.; Fukui, Y.; Aoyama, H.; Fujiwara, M.; Fuji, J.; Inouye, M.; Iwase, T.; Kihara, T.; Oi, A.; Otani, H.; Shinomiya, M.; Sugioka, K.; Yamano, T.; Yamashita, K.H.; Tanimura, T. 2007: Comments from the Developmental Neurotoxicology Committee of the Japanese Teratology Society on the OECD Guideline for the Testing of Chemicals, Proposal for a New Guideline 426, Developmental Neurotoxicity Study, Draft Document (October 2006 version), and on the Draft Document of the Retrospective Performance Assessment of the Draft Test Guideline 426 on Developmental Neurotoxicity Congenital anomalies 47(2): 74-76
Reeve, H.L.; Archer, S.L.; Soper, M.; Weir, E.K. 1999: Dexfenfluramine increases pulmonary artery smooth muscle intracellular Ca2+, independent of membrane potential American Journal of Physiology 277(3): L662-L666
Guy-Grand, B. 1992: INDEX (international dexfenfluramine study) as a model for long-term pharmacotherapy of obesity in the 1990s International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 16 Suppl. 3: S5-14
Finer, N. 1992: Body weight evolution during dexfenfluramine treatment after initial weight control International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 16(Suppl 3): S25-S29
Weir, E.K.; Reeve, H.L.; Huang, J.M.; Michelakis, E.; Nelson, D.P.; Hampl, V.; Archer, S.L. 1996: Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction Circulation 94(9): 2216-2220
Aggarwal, P. 1994: INH-induced neurotoxicity Journal of the Association of Physicians of India 42(5): 429